APA (7th ed.) Citation

McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., . . . Wright, S. (2018). Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. The American journal of psychiatry, 175(3), 225-231. https://doi.org/10.1176/appi.ajp.2017.17030325

Chicago Style (17th ed.) Citation

McGuire, Philip, Philip Robson, Wieslaw Jerzy Cubala, Daniel Vasile, Paul Dugald Morrison, Rachel Barron, Adam Taylor, and Stephen Wright. "Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial." The American Journal of Psychiatry 175, no. 3 (2018): 225-231. https://doi.org/10.1176/appi.ajp.2017.17030325.

MLA (9th ed.) Citation

McGuire, Philip, et al. "Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial." The American Journal of Psychiatry, vol. 175, no. 3, 2018, pp. 225-231, https://doi.org/10.1176/appi.ajp.2017.17030325.